Vanderbilt-Ingram Cancer Center Patients Treated with New FDA-Approved CAR T Therapy – Newswise (press release)
Winchester Herald Chronicle |
Vanderbilt-Ingram Cancer Center Patients Treated with New FDA-Approved CAR T Therapy
Newswise (press release) Newswise — Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of … Gene therapies turn tables on cancer |
